REALIZING MODERN MEDICINE'S DREAM OF IMMEDIATE HEMOSTASIS

Rutledge Ellis-Behnke
Brain and Cognitive Sciences
Hemostasis, or the cessation of blood loss, is a major challenge
confronting healthcare providers on the battlefield, in the ambulance
or emergency room, and in surgery. There are several hemostatic
agents on the market, but few can be left inside the patient, and
none assure immediate and complete hemostasis before clotting.
This project will explore the commercialization of a remarkable
new compound that rapidly forms a transparent, nanofiber-rich meshwork
that stops bleeding instantly, allows wounds to begin healing quickly,
promotes tissue regeneration, and breaks down harmlessly within
the body. The transparent, fluid material can be easily applied
to wet or dry surfaces. Surgery can be performed through it, enabling
faster, more accurate, and safer operations. Third-party testing
shows that the material is non-toxic and safe to use internally
and externally. Moreover, it does not require removal, because
its breakdown products can be used by cells in the healing process.
This project will explore the material's viability in surgery,
post-traumatic treatments, and veterinary medicine, with chronic
wound care and consumer first-aid being additional potential markets
for this disruptive technology.
|